
- MHE May 2021
- Volume 31
- Issue 5
AIDS Group Says ACA Plan Copay Accumulators are More Common Than Not
Copay accumulators are a common feature in health insurance plans sold on the ACA exchanges, according to a recent report from an AIDS advocacy group that wants the Biden administration to reverse a decision made by the Trump administration that allowed continued use of accumulators.
Copay accumulators are a common feature in health insurance plans sold on the ACA exchanges, according to a recent report from an AIDS advocacy group that wants the Biden administration to reverse a decision made by the Trump administration that allowed continued use of accumulators.
The AIDS Institute issued a report in March that says that at least two-thirds of the ACA health plans in 35 states include a copay accumulator and that in 14 states, every plan does.
Copay accumulators remove any copay assistance that members receive from spending that would count toward a health plan’s deductible. Patient advocacy groups say accumulators undermine copay assistance and protection against the high cost of drugs. And the AIDS Institute says in its report that they doubly benefit insurers and PBMs because they receive the copay assistance funds and then the amount the member spends until the plan’s out-of-pocket maximum is reached. The counterargument from insurers and PBMs is that accumulators sabotage formularies and wind up making healthcare and premiums more expensive.
Last year, the Trump administration moved to limit accumulators and then reversed course. The AIDS Institute wants the Biden administration to change the Trump administration’s policy and rein in the use of accumulators.
Articles in this issue
over 4 years ago
3 Takeaways About Managing the Cost of MSover 4 years ago
The Rise in Formulary Exclusionsover 4 years ago
Digital Behavioral Health is Growing Hand Over Fistover 4 years ago
Patient-Centered Medical Homes: Were They Built to Last?over 4 years ago
Playing it Safe and Secure Amidst Online Vaccine Securityover 4 years ago
How the New Price Transparency Rules are Affecting Stakeholdersover 4 years ago
Pandemic May Lead to Further Provider Consolidationover 4 years ago
New Hemophilia Treatments Look to Cut Number of Infusionsover 4 years ago
Herd Immunity May Depend on Persuading “Conspiracy Believers”Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.